Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses (Q33488897)

27 July 2017

0 references

1 reference

title

Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses (English)

1 reference

27 July 2017

0 references

1 reference

1 reference

1 reference

P Glasziou

2

0 references

Rafael Perera

1 reference

ORCID Public Data File 2021

Rury Holman

series ordinal

4

object named as

R R Holman

1 reference

27 July 2017

D S Lasserson

1

1 reference

27 July 2017

R Perera

series ordinal

3

1 reference

27 July 2017

A J Farmer

series ordinal

5

1 reference

27 July 2017

31 July 2009

1 reference

27 July 2017

1 reference

27 July 2017

52

1 reference

27 July 2017

10

1 reference

27 July 2017

1990-2000

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-009-1468-7

27 July 2017

0 references

cites work

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-009-1468-7

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-009-1468-7

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-009-1468-7

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

21 January 2018

1 reference

12 December 2020

Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.

1 reference

12 December 2020

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

1 reference

12 December 2020

Type 2 diabetes mellitus: what is the optimal treatment regimen?

1 reference

12 December 2020

Diabetes mellitus. Report of a WHO Study Group

1 reference

12 December 2020

First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence

1 reference

12 December 2020

Insulin regimens for the non-insulin dependent: impact on diurnal metabolic state and quality of life.

1 reference

12 December 2020

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy

1 reference

12 December 2020

Comparison of Basal and Prandial Insulin Therapy in Patients with Secondary Failure of Sulphonylurea Therapy

1 reference

12 December 2020

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

Quantifying heterogeneity in a meta-analysis

1 reference

12 December 2020

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week

1 reference

12 December 2020

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus

1 reference

12 December 2020

Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy

1 reference

12 December 2020

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin

1 reference

12 December 2020

Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.

1 reference

12 December 2020

Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

1 reference

12 December 2020

Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control.

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Evaluation of risk factors for development of complications in Type II diabetes in Europe

1 reference

12 December 2020

Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

1 reference

12 December 2020

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11).

1 reference

12 December 2020

Meta-analyses involving cross-over trials: methodological issues

1 reference

12 December 2020

A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes

1 reference

12 December 2020

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

12 December 2020

Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure

1 reference

12 December 2020

A randomised trial of insulin on well-being and carer strain in elderly type 2 diabetic subjects

1 reference

12 December 2020

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

1 reference

12 December 2020

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

12 December 2020

Combined bedtime insulin--daytime sulphonylurea regimen compared with two different daily insulin regimens in type 2 diabetes: effects on HbA1c and hypoglycaemia rate--a randomised trial

1 reference

12 December 2020

Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study.

1 reference

12 December 2020

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

1 reference

12 December 2020

Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors

1 reference

12 December 2020

Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data

1 reference

12 December 2020

A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents

1 reference

12 December 2020

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

12 December 2020

Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study

1 reference

12 December 2020

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

12 December 2020

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

12 December 2020

Making the transition from oral to insulin therapy

1 reference

12 December 2020

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

1 reference

12 December 2020

Insulins today and beyond

1 reference

12 December 2020

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes

1 reference

12 December 2020

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

12 December 2020

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

12 December 2020

Efficacy of biphasic insulin aspart in patients with type 2 diabetes

1 reference

12 December 2020

Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

1 reference

12 December 2020

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe

1 reference

12 December 2020

10.1007/S00125-009-1468-7

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference